Over the last decade, goal-directed management of osteoporosis has been developed as a concept. In 2024, a working group of ...
What European Commission marketing authorisation of a teriparatide biosimilar means for osteoporosis
This month, the European Commission granted centralised marketing authorisation for Zandoriah (teriparatide), a biosimilar to ...
As discussed in a previous article "Move it or lose it," if we are not working to prevent bone density loss, we can become ...
Scientists from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed) have identified how the protein Piezo1 translates physical ...
A research team from the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed) has uncovered a key biological mechanism that explains how ...
The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density ...
Seoul National University College of Engineering (SNU Engineering) announced that a joint research team led by Prof. Sunghoon Kwon (Department of Electrical and Computer Engineering, SNU) and Prof.
The US Food and Drug Administration (FDA) on Monday issued new draft guidance calling for drugmakers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. According to FDA ...
Postmenopausal osteoporosis continues to be a growing and costly global public health challenge. In recent interviews conducted by the American Journal of Managed Care®, this topic was explored by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results